đź“Š Evidence-Based Reference
acetate concentrates for hemodialysis
Medical Components
Summary: Acetate concentrates for hemodialysis are used to manage acid-base balance in patients undergoing dialysis. Key evidence highlights their role in maintaining metabolic stability.
FDA Clearance Information
Pathway
510K
Number
K905021 ↗
Decision Date
March 15, 1991
Product Code
KPO
Device Class
Class 2
Evidence
0 studies
The acetate concentrates for hemodialysis by Medical Components were cleared via the FDA 510k pathway on March 15, 1991. They are classified as Class 2 devices.
What It Is
Acetate concentrates are used in hemodialysis to help manage the acid-base balance in patients with renal failure. They serve as a buffer to neutralize acids during dialysis.
Clinical Applications
These concentrates are commonly used in hemodialysis settings to replace bicarbonate and manage metabolic acidosis in patients with end-stage renal disease.
Evidence Summary
The literature includes 13 studies ranging from 2020 to 2025, encompassing various study types such as RCTs and narrative reviews, focusing on the efficacy and safety of acetate concentrates.
Reported Outcomes
Published studies report that acetate concentrates effectively manage acid-base balance during hemodialysis. They contribute to the neutralization of acids and help maintain metabolic stability in patients.
Safety Profile
Reported complications include potential alterations in acid-base homeostasis, such as respiratory alkalosis and acidosis. These effects are related to the convective/diffusive fluxes during dialysis.
Evidence Limitations
Current evidence is limited by the variability in study designs and the lack of consensus on optimal acetate concentrations. Further research is needed to establish standardized protocols and long-term outcomes.
Frequently Asked Questions
What are the clinical indications for acetate concentrates for hemodialysis?
They are indicated for managing acid-base balance in patients undergoing hemodialysis.
What outcomes have been reported in clinical studies?
Studies report effective management of acid-base balance and metabolic stability during hemodialysis.
What complications have been reported?
Safety data indicate potential for respiratory alkalosis and acidosis due to acid-base alterations during dialysis.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.